header-logo header-logo

27 April 2018 / Sarah Moore
Issue: 7790 / Categories: Features , Health & safety
printer mail-detail

Power to the people

nlj_7790_moore

Sarah Moore reviews the current state of product liability in the UK, & asks: is it time for a consumer revolution?

  • A recently announced review may be a sign that the regulatory and legislative frameworks surrounding pharmaceuticals and medical devices are no longer fit for purpose.

On 21 February 2018, the government announced an official review into the way in which consumer concerns have been handled by regulators and lawmakers in the UK. The review, to be chaired by Baroness Cumberlege, will focus on three specific products marketed historically and/or currently within the UK, including:

  • Primodos—a hormone-based pregnancy test used in the UK between 1953-75 which campaigners allege has caused birth defects in their children.
  • Sodium Valproate—a drug to control epilepsy, marketed in the UK since the 1970s and still available; alleged to have caused physical and cognitive birth defects in children born to mothers using the drug at the time of conception.
  • Vaginal mesh—a medical device, still available in the UK, allegedly associated with extreme pain and damage to internal organs of
If you are not a subscriber, subscribe now to read this content
If you are already a subscriber sign in
...or Register for two weeks' free access to subscriber content

MOVERS & SHAKERS

Walkers—Muriel Marseille

Walkers—Muriel Marseille

Ashurst's Chief Risk Officer joins Walkers

Excello Law—John Osborne

Excello Law—John Osborne

Northern family lawyer John Osborne joins Excello

mfg Solicitors—Rebecca Rogers, Kennedy Langley & Victoria Griffiths

mfg Solicitors—Rebecca Rogers, Kennedy Langley & Victoria Griffiths

Trio of promotions announced at Kidderminster law firm mfg Solicitors

NEWS
A sole director can conspire with their own company for the purposes of the tort of unlawful means conspiracy, the High Court has ruled in a judgment with potentially wide implications for business disputes
The Court of Appeal has reinforced that domicile depends on intention rather than residence alone, in a significant post-Brexit ruling on cross-border financial remedy claims
The Chancery Division's long history comes to an end this autumn as it is reborn as the Business and Property Division, prompting questions over whether the shake-up is really necessary
The Financial Conduct Authority (FCA) continues to show that failing to disclose regulatory issues can attract harsher consequences than the original misconduct itself
Rejecting a generous settlement can prove an expensive mistake, as two recent high-profile cases demonstrate
back-to-top-scroll